Parathyroidectomy Rates Stable Despite Changes in Medical Therapy
The debate continues on how best to use parathyroidectomy to treat severe SHPT.
The debate continues on how best to use parathyroidectomy to treat severe SHPT.
Researchers found insignificant differences between the 2 surgeries in SHPT persistence and recurrence.
Intact parathyroid hormone levels fell significantly in all patients who underwent total Ptx with autotransplant and 91.6% of subtotal Ptx patients.
In a study, ioPTH decay at 30 minutes post-excision was highly accurate in predicting persistent SHPT.
Study finds a 20% to 25% lower risk for early death over the long term.
Postoperative parathyroid hormone levels of 16.6 pg/mL or higher are associated with a 3-fold increased risk of cardiovascular death.
Lowest relative risk of death observed in patients with serum phosphorus and calcium levels of 4.4 mg/dL and 8.8 mg/dL, respectively.
One-third of patients who missed clinical targets for phosphorus, calcium and/or parathormone remained untreated.
A new study suggests that non-oxidized, biologically active PTH testing may help determine mortality risk in hemodialysis patients.
Novel assay can distinguish between oxidized and nonoxidized forms of parathyroid hormone.